Correlation Between Larimar Therapeutics and Genelux Common
Can any of the company-specific risk be diversified away by investing in both Larimar Therapeutics and Genelux Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Larimar Therapeutics and Genelux Common into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Larimar Therapeutics and Genelux Common, you can compare the effects of market volatilities on Larimar Therapeutics and Genelux Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Larimar Therapeutics with a short position of Genelux Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Larimar Therapeutics and Genelux Common.
Diversification Opportunities for Larimar Therapeutics and Genelux Common
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Larimar and Genelux is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Larimar Therapeutics and Genelux Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genelux Common and Larimar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Larimar Therapeutics are associated (or correlated) with Genelux Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genelux Common has no effect on the direction of Larimar Therapeutics i.e., Larimar Therapeutics and Genelux Common go up and down completely randomly.
Pair Corralation between Larimar Therapeutics and Genelux Common
Given the investment horizon of 90 days Larimar Therapeutics is expected to under-perform the Genelux Common. In addition to that, Larimar Therapeutics is 1.03 times more volatile than Genelux Common. It trades about -0.26 of its total potential returns per unit of risk. Genelux Common is currently generating about 0.15 per unit of volatility. If you would invest 256.00 in Genelux Common on October 25, 2024 and sell it today you would earn a total of 72.00 from holding Genelux Common or generate 28.13% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Larimar Therapeutics vs. Genelux Common
Performance |
| Timeline |
| Larimar Therapeutics |
| Genelux Common |
Larimar Therapeutics and Genelux Common Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Larimar Therapeutics and Genelux Common
The main advantage of trading using opposite Larimar Therapeutics and Genelux Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Larimar Therapeutics position performs unexpectedly, Genelux Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genelux Common will offset losses from the drop in Genelux Common's long position.| Larimar Therapeutics vs. Vaxcyte | Larimar Therapeutics vs. Syndax Pharmaceuticals | Larimar Therapeutics vs. Merus BV | Larimar Therapeutics vs. Sutro Biopharma |
| Genelux Common vs. Dyadic International | Genelux Common vs. Cingulate | Genelux Common vs. Monopar Therapeutics | Genelux Common vs. Terns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |